About: Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.28 (+7.56%)
ALZN NASDAQ Alzamend Neuro Inc
Alzamend Neuro Inc share price
Atividade de preço de ALZN
Último preço
$ 1,190
Variação (24h)
0,06 USD (5,31%)
Volume
21.36K
Volume (média 4 sem.)
-
Abertura
$ 1,16
Variação do dia
$ 1,12 - $ 1,23
Fechamento anterior
$ 1,13
Último negócio
28 Oct, 8:00 pm GMT+0
Atrasado
28 Oct, 8:00 pm GMT+0
ALZN price performance
Atrasado
28 Oct, 8:00 pm GMT+0
quote.marketSignals